Parasite payback

Leishmania might be vulnerable to a common anticancer drug

7:21pm, June 10, 2008

The breast cancer drug tamoxifen kills the single-celled parasite known as leishmania, a scourge common in the tropics, Brazilian scientists report. While the tests in mice are preliminary, the finding is heartening because few good treatments for leishmaniasis exist, says Silvia Uliana, a physician at the University of São Paulo.

This article is available only to subscribing members. Join SSP today or Log in.

More from Science News